Nutriband met with US FDA to obtain feedback on the Chemistry, Manufacturing, and Controls plans for AVERSA™ FENTANYL (abuse deterrent ...

Nutriband met with US FDA to obtain feedback on the Chemistry, Manufacturing, and Controls plans for AVERSA FENTANYL (abuse deterrent transdermal system) through commercialization. Nutriband received ...

Nutriband is developing the product in partnership with Kindeva, combining Nutriband’s AVERSA™ abuse-deterrent technology with Kindeva’s FDA-approved fentanyl patch. The company estimates AVERSA™ ...

Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) has announced that Company founder, Gareth Sheridan has returned as Company CEO. During the period of August 10 until October 27 , Co-Founder and Chairman, ...

Featured In Channelchek Report Highlighting AVERSA Fentanyl Progress. Nutriband (NASDAQ: NTRB), a pharmaceutical company developing transdermal drug delivery technologies, was featured in a Channelche ...

Nutriband (NASDAQ: NTRB), a pharmaceutical company developing transdermal drug delivery technologies, was featured in a Channelchek report by Noble Capital Markets summarizing its presentation at ...

Nutriband ( ($NTRB) ) has shared an update. Nutriband Inc. announced the successful completion of a meeting with the US FDA regarding its AVERSA™ ...

Nutriband said Mr Sheridan would guide the company through the rest of the year with the target of a new drug filing for the US Food and Drug Administration in 2026 for its fentanyl patch ...

Founder Gareth Sheridan Returns As CEO To Lead Final Development Phase Of AVERSA Fentanyl. Nutriband (NASDAQ: NTRB) today announced that company founder Gareth Sheridan has resumed his role as CEO, ...

The Montgomery County Precinct 4 Constable's Office is investigating after two county employees say they were handed a flyer ...

One of US President Donald Trump’s first actions against China following his re-election was to impose a 10% tariff on ...